FDA indicates that a recent update to the instructions constitutes a Class I recall, since problems with the Impella Blood Pumps can lead to severe injury or death
Researchers found a significantly increased risk of heart problems linked to ADHD drugs, but say the risks are not high enough to recommend avoiding use of the medications.
FDA has classified problems with the communication system as a Class 1 HeartMate recall, indicating that continued use of the device may pose a risk of serious injuries or death.
Decreased kidney function makes it harder for the body to filter out digoxin, which could cause the heart drug to a buildup in toxicity, researchers warn.
There was little difference in rates of death or hospitalization between patients given Injectafer or a placebo, researchers found.
More than two dozen incidents have been reported in connection to the Medtronic implantable cardiac defibrillator recall, including 22 injuries caused by problems with low energy output
Heart failure risks from anthracycline were linked to high doses, as well as long-term and short-term side effects
FDA says Abiomed Impella RP Heart Pump Systems are safe enough to use, but must be limited to specific patient populations.
Nearly 20% of heart failure patients wind up being re-admitted to the hospital within 30 days, researchers found.
The rate of hospital errors and adverse events dropping suggests that many hospital complications are preventable, federal researchers said.
